Paediatric trigger thumbs: patient-reported outcome measures over a minimum of ten years' follow-up

Sebastian Farr1, Teofil Mataric2, Bettina Kroyer3

  • 1Department of Pediatric Orthopaedics and Foot and Ankle Surgery, Orthopaedic Hospital Speising, Vienna, Austria.

Bone & Joint Open
|September 3, 2024
PubMed

Insights

A1 pulley release effectively treats paediatric trigger thumb, offering excellent long-term function and high patient satisfaction. Early surgical intervention may lead to even better outcomes for this common condition.

Area of Science:

  • Orthopaedic Surgery
  • Paediatric Hand Conditions
  • Clinical Outcomes Research

Background:

  • Paediatric trigger thumb is a distinct condition with unique anatomical features.
  • Surgical intervention, specifically A1 pulley release, is a common treatment approach.
  • Long-term outcomes and patient-reported satisfaction require further investigation.

Purpose of the Study:

  • To evaluate the long-term functional outcomes of A1 pulley release in idiopathic paediatric trigger thumbs.
  • To assess patient satisfaction using established patient-reported outcome measures.
  • To identify factors influencing outcomes, such as age at surgery.

Main Methods:

  • A cross-sectional, questionnaire-based study was conducted.
  • 67 patients with idiopathic paediatric trigger thumbs, who underwent A1 pulley release (2004-2011), were included.
  • Long-term follow-up (median 15 years) included QuickDASH scores and range of motion assessment.

Main Results:

  • Excellent functional outcomes were reported, with a median QuickDASH score of 0.
  • High patient satisfaction was observed (84% reported maximal satisfaction).
  • No residual triggering or need for revision surgery was noted; Notta's nodule resolved in 73%.

Conclusions:

  • A1 pulley release is an effective and acceptable procedure for paediatric trigger thumb, yielding excellent long-term results.
  • Earlier surgical intervention showed a trend towards higher patient satisfaction.
  • The procedure demonstrates durable efficacy with minimal complications.
Abstract